Rohinton Edalji
AbbVie (United States)(US)
Publications by Year
Research Areas
Hemoglobin structure and function, Hemoglobinopathies and Related Disorders, Mass Spectrometry Techniques and Applications, Neonatal Health and Biochemistry, Peptidase Inhibition and Analysis
Most-Cited Works
- → Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours(2017)825 cited
- → Structural Characterization of a Soluble Amyloid β-Peptide Oligomer(2009)352 cited
- → NMR studies of [U-13C] cyclosporin A bound to cyclophilin: bound conformation and portions of cyclosporin involved in binding(1991)192 cited
- → Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor(2017)134 cited
- → The small molecule ISRIB rescues the stability and activity of Vanishing White Matter Disease eIF2B mutant complexes(2018)134 cited
- → Isotope-Edited NMR of Cyclosporin a Bound to Cyclophilin: Evidence for a Trans 9,10 Amide Bond(1990)119 cited